- Home
- ADVM vs MOBX Comparison
ADVM vs MOBX Comparison
Compare ADVM & MOBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVM
- MOBX
- Stock Information
- Founded
- ADVM 2006
- MOBX 2020
- Country
- ADVM United States
- MOBX United States
- Employees
- ADVM N/A
- MOBX N/A
- Industry
- ADVM Biotechnology: Biological Products (No Diagnostic Substances)
- MOBX
- Sector
- ADVM Health Care
- MOBX
- Exchange
- ADVM Nasdaq
- MOBX Nasdaq
- Market Cap
- ADVM 66.3M
- MOBX 57.1M
- IPO Year
- ADVM 2014
- MOBX N/A
- Fundamental
- Price
- ADVM $3.02
- MOBX $0.93
- Analyst Decision
- ADVM Strong Buy
- MOBX
- Analyst Count
- ADVM 4
- MOBX 0
- Target Price
- ADVM $19.75
- MOBX N/A
- AVG Volume (30 Days)
- ADVM 84.1K
- MOBX 1.7M
- Earning Date
- ADVM 11-03-2025
- MOBX 08-13-2025
- Dividend Yield
- ADVM N/A
- MOBX N/A
- EPS Growth
- ADVM N/A
- MOBX N/A
- EPS
- ADVM N/A
- MOBX N/A
- Revenue
- ADVM $1,000,000.00
- MOBX $10,984,000.00
- Revenue This Year
- ADVM $1,836.70
- MOBX N/A
- Revenue Next Year
- ADVM N/A
- MOBX N/A
- P/E Ratio
- ADVM N/A
- MOBX N/A
- Revenue Growth
- ADVM N/A
- MOBX 180.13
- 52 Week Low
- ADVM $1.78
- MOBX $0.55
- 52 Week High
- ADVM $8.56
- MOBX $2.47
- Technical
- Relative Strength Index (RSI)
- ADVM 50.02
- MOBX 45.49
- Support Level
- ADVM $2.93
- MOBX $1.00
- Resistance Level
- ADVM $3.59
- MOBX $1.19
- Average True Range (ATR)
- ADVM 0.22
- MOBX 0.16
- MACD
- ADVM -0.02
- MOBX -0.01
- Stochastic Oscillator
- ADVM 13.64
- MOBX 14.17
About ADVM Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.
About MOBX Mobix Labs Inc.
Mobix Labs Inc. specializes in designing, developing, and selling components and systems for wireless and wired connectivity, radio frequency (RF) technologies, switching, and electromagnetic interference (EMI) filtering solutions. The company serves markets, including commercial, industrial, automotive, medical, aerospace, defense, and others.